Healthlead Public Company Limited

THAMSE:HL-F Stock Report

Market Cap: ฿6.8b

Healthlead Future Growth

Future criteria checks 4/6

Healthlead is forecast to grow earnings and revenue by 24.2% and 19.2% per annum respectively. EPS is expected to grow by 19% per annum. Return on equity is forecast to be 15.9% in 3 years.

Key information

24.2%

Earnings growth rate

19.0%

EPS growth rate

Consumer Retailing earnings growth19.5%
Revenue growth rate19.2%
Future return on equity15.9%
Analyst coverage

Low

Last updatedn/a

Recent future growth updates

No updates

Recent updates

Earnings and Revenue Growth Forecasts

THAMSE:HL-F - Analysts future estimates and past financials data (THB Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20242,226194201N/A1
12/31/20231,879151154N/A1
12/31/20221,491127155N/A1
3/31/20221,3329672142N/A
12/31/20211,216807085N/A
9/30/20211,1967194109N/A
3/31/20211,030443246N/A
1/1/20211,080528297N/A
12/31/201993522N/AN/AN/A
12/31/201879102033N/A
12/31/2017701-9N/AN/AN/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: HL-F's forecast earnings growth (24.2% per year) is above the savings rate (2%).

Earnings vs Market: HL-F's earnings (24.2% per year) are forecast to grow faster than the TH market (18.8% per year).

High Growth Earnings: HL-F's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: HL-F's revenue (19.2% per year) is forecast to grow faster than the TH market (5.3% per year).

High Growth Revenue: HL-F's revenue (19.2% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: HL-F's Return on Equity is forecast to be low in 3 years time (15.9%).


Discover growth companies